Enzon Pharmaceuticals, Inc. – OTC:ENZN

Enzon Pharmaceuticals stock price today

$0.09
-0.08
-47.98%
Financial Health
0
1
2
3
4
5
6
7
8
9

Enzon Pharmaceuticals stock price monthly change

+1.76%
month

Enzon Pharmaceuticals stock price quarterly change

+1.76%
quarter

Enzon Pharmaceuticals stock price yearly change

+87.23%
year

Enzon Pharmaceuticals key metrics

Market Cap
 19.66M
Enterprise value
 N/A
P/E
 -11.57
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 660.79
Price/Book
 5.04
PEG ratio
 -0.34
EPS
 N/A
Revenue
 N/A
EBITDA
 -1.08M
Income
 1.49M
Revenue Q/Q
 N/A
Revenue Y/Y
 -100%
Profit margin
 -5619.23%
Oper. margin
 -2307.69%
Gross margin
 0%
EBIT margin
 -2307.69%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Enzon Pharmaceuticals stock price history

Enzon Pharmaceuticals stock forecast

Enzon Pharmaceuticals financial statements

Profit Margin

Enzon Pharmaceuticals, Inc. (OTC:ENZN): Profit margin
Jun 2023 0 183K
Sep 2023 0 321K
Dec 2023 0 672K
Mar 2024 0 320K
ENZN income statement history
0%
Yield TTM
Enzon Pharmaceuticals, Inc. (OTC:ENZN): Payout ratio
Payout ratio 0%
Enzon Pharmaceuticals, Inc. (OTC:ENZN): Dividend Yield
2019 87.38%
2020 3.62%
2021 7.96%
2022 6.97%
2023 18.36%
ENZN dividends history

Debt to Assets

Enzon Pharmaceuticals, Inc. (OTC:ENZN): Debt to assets
Jun 2023 46672000 402K 0.86%
Sep 2023 46997000 44.48M 94.65%
Dec 2023 47702000 1.71M 3.59%
Mar 2024 46829000 521K 1.11%
ENZN balance sheet history

Cash Flow

Enzon Pharmaceuticals, Inc. (OTC:ENZN): Cash Flow
Jun 2023 254K 0 0
Sep 2023 426K 0 0
Dec 2023 455K 0 0
Mar 2024 251K 0 -1.27M
ENZN cash flow history

Enzon Pharmaceuticals other data

Enzon Pharmaceuticals
Insider Trading

Enzon Pharmaceuticals, Inc. (OTC:ENZN): Insider trades (number of shares)
Period Buy Sel
Jun 2023 99550 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
READ RANDOLPH C director
 Common Stock 84,550 $0.14 $11,922
Purchase
READ RANDOLPH C director
 Common Stock 15,000 $0.13 $1,995
Sale
COUCHMAN JONATHAN 10 percent owner
 Common Stock, $0.01 par value 57,500 $0.39 $22,425
Sale
COUCHMAN JONATHAN 10 percent owner
 Common Stock, $0.01 par value 50,000 $0.39 $19,500
Purchase
READ RANDOLPH C director
 Common Stock 50,000 $0.16 $7,900
Purchase
READ RANDOLPH C director
 Common Stock 50,450 $0.15 $7,618
Purchase
BLEZNICK JORDAN director
 Common Stock 100,000 $0.15 $15,400
Sale
COUCHMAN JONATHAN 10 percent owner
 Common Stock, $0.01 par value 25,000 $0.19 $4,775
Sale
COUCHMAN JONATHAN 10 percent owner
 Common Stock, $0.01 par value 52,100 $0.18 $9,534
Purchase
COUCHMAN JONATHAN 10 percent owner
 Common Stock, $0.01 par value 506,292 $0.2 $101,258
ENZN insider trading transactions

Enzon Pharmaceuticals
Executives

Insider Compensation
Mr. Richard L. Feinstein (1943) Chief Executive Officer, Chief Financial Officer & Company Sec.
 $183,940

Frequently Asked Questions (FAQ)

  • What's the price of Enzon Pharmaceuticals stock today?

    One share of Enzon Pharmaceuticals stock can currently be purchased for approximately $0.09.

  • When is Enzon Pharmaceuticals's next earnings date?

    Unfortunately, Enzon Pharmaceuticals's (ENZN) next earnings date is currently unknown.

  • Does Enzon Pharmaceuticals pay dividends?

    No, Enzon Pharmaceuticals does not pay dividends.

  • How much money does Enzon Pharmaceuticals make?

    Enzon Pharmaceuticals has a market capitalization of 19.66M.

  • What is Enzon Pharmaceuticals's stock symbol?

    Enzon Pharmaceuticals, Inc. is traded on the OTC under the ticker symbol "ENZN".

  • What is Enzon Pharmaceuticals's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Enzon Pharmaceuticals?

    Shares of Enzon Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Enzon Pharmaceuticals's key executives?

    Enzon Pharmaceuticals's management team includes the following people:

    • Mr. Richard L. Feinstein Chief Executive Officer, Chief Financial Officer & Company Sec.(age: 82, pay: $183,940)

  • When Enzon Pharmaceuticals went public?

    Enzon Pharmaceuticals, Inc. is publicly traded company for more then 41 years since IPO on 15 Feb 1984.

  • What is Enzon Pharmaceuticals's official website?

    The official website for Enzon Pharmaceuticals is enzon.com.

  • Where are Enzon Pharmaceuticals's headquarters?

    Enzon Pharmaceuticals is headquartered at 20 Commerce Drive, Cranford, NJ.

  • How can i contact Enzon Pharmaceuticals?

    Enzon Pharmaceuticals's mailing address is 20 Commerce Drive, Cranford, NJ and company can be reached via phone at +7 329804500.

Enzon Pharmaceuticals company profile:

Enzon Pharmaceuticals, Inc.

enzon.com
Exchange:

OTC

Full time employees:

0

Industry:

Biotechnology

Sector:

Healthcare

Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.

+7 329804500
20 Commerce Drive
Cranford, NJ 07016

CIK: 0000727510
ISIN: US2939041081
: